🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,920 results for “IO” Clear

  1. 0.9% w/v sodium chloride solution for intravenous infusion, Panzyga 100 mg/ml Infusionslösung

    Maze Therapeutics

    Pediatric acute-onset neuropsychiatric syndrome (PANS)

    phase 3 small molecule active

    1 trial

  2. 1% Clascoterone Cream

    Sunshine Biopharma

    Acne Vulgaris

    phase 3 small molecule active

    1 trial

  3. 1.0% C31G SAVVY vaginal gel

    United Therapeutics Europe Ltd

    HIV Infections

    phase 3 small molecule active

    2 trials

  4. 1.0mg/kg/day PRAX-562

    PRECISION BIOSCIENCES INC

    Developmental and Epileptic Encephalopathy 1

    phase 3 small molecule active

    1 trial

  5. 10-week smoking cessation group therapy combined with NicoDerm CQ

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Cessation

    phase 3 other completed

    1 trial

  6. 11C-SB207145, 11C-DASB

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Parkinson's disease, Prodromal phase of Parkinson's disease

    phase 3 small molecule active

    1 trial

  7. 12-Valent Pneumococcal Conjugate Vaccine

    MAIA Biotechnology

    Pneumococcal Vaccines

    phase 3 mab active

    1 trial

  8. 177Lu-TLX250

    Telix Innovations

    ccRCC

    phase 3 other active

    1 trial

  9. 177Lu-TLX591

    Telix Innovations

    Metastatic Castration-resistant Prostate Cancer

    phase 3 small molecule active

    1 trial

  10. 18F fluciclovine

    PRECISION BIOSCIENCES INC

    Brain Metastases

    phase 3 small molecule completed

    2 trials

  11. 18F-AV-1451

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Maladie d' Alzheimer, Alzheimer's pathology

    phase 3 small molecule active

    1 trial

  12. 18F-LBT-999

    Institut für biomedizinische Analytik NMR-Imaging GmbH

    Comatose Traumatic Brain Injury patients

    phase 3 small molecule active

    1 trial

  13. 1:1:1 Blood Transfusion Ratio

    United Therapeutics Europe Ltd

    Trauma

    phase 3 mab completed

    1 trial

  14. 1mg elsunersen

    PRECISION BIOSCIENCES INC

    Epileptic Encephalopathy

    phase 3 small molecule active

    1 trial

  15. 2 cycles induction chemotherapy

    First Tracks Biotherapeutics

    Locally Advanced Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  16. 2-mg Intravitreous Aflibercept Injection

    Regeneron UK Limited

    Proliferative Diabetic Retinopathy

    phase 3 small molecule completed

    1 trial

  17. 20 mg sildenafil citrate by mouth

    First Tracks Biotherapeutics

    Pulmonary Hypertension

    phase 3 small molecule active

    1 trial

  18. 20mg/day PRAX-628 for 6 weeks then 30mg/day PRAX-628 for remaining 6 weeks

    PRECISION BIOSCIENCES INC

    Focal Seizure

    phase 3 small molecule active

    1 trial

  19. 25 mg Ontamalimab

    Takeda Pharmaceuticals International AG

    Crohn's Disease

    phase 3 small molecule completed

    1 trial

  20. 3-N-butylphthalide

    First Tracks Biotherapeutics

    Multiple System Atrophy

    phase 3 small molecule active

    1 trial

  21. 3-dimensional conformal radiation therapy

    United Therapeutics Europe Ltd

    Head and Neck Cancer

    phase 3 other active

    1 trial

  22. 36-71 months old children-experimental EV71 vaccine.

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

  23. 40 mg/day vormatrogine for 12 weeks

    PRECISION BIOSCIENCES INC

    Focal Epilepsy

    phase 3 small molecule active

    1 trial

  24. 400U /0.5ml EV71 vaccine

    SINOVAC BIOTECH LTD

    Hand, Foot and Mouth Disease

    phase 3 mab completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources